SNCA and Parkinson disease: To further confirm the specificity of UBA52 in pathological conditions, the SH-SY5Y cells were transiently overexpressed with wild-type α-synuclein (Myc-α-SYN) to imitate the PD conditions, and the interaction of UBA52 with HSP90 and CHIP was evaluated.